ES2150585T3 - Procedimiento para la evaluacion diagnostica y el control de la evolucion de estados de choque en seres humanos, asi como medicamentos para su terapia. - Google Patents

Procedimiento para la evaluacion diagnostica y el control de la evolucion de estados de choque en seres humanos, asi como medicamentos para su terapia.

Info

Publication number
ES2150585T3
ES2150585T3 ES95935420T ES95935420T ES2150585T3 ES 2150585 T3 ES2150585 T3 ES 2150585T3 ES 95935420 T ES95935420 T ES 95935420T ES 95935420 T ES95935420 T ES 95935420T ES 2150585 T3 ES2150585 T3 ES 2150585T3
Authority
ES
Spain
Prior art keywords
shock
medicines
evolution
therapy
states
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95935420T
Other languages
English (en)
Inventor
Holger Bang
Kay Brune
Albrecht Wendel
Gesa Tiegs
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PAZ ARZNEIMITTELENTWICKLUNG
Original Assignee
PAZ ARZNEIMITTELENTWICKLUNG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PAZ ARZNEIMITTELENTWICKLUNG filed Critical PAZ ARZNEIMITTELENTWICKLUNG
Application granted granted Critical
Publication of ES2150585T3 publication Critical patent/ES2150585T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/533—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving isomerase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/106664—Blood serum or blood plasma standard or control

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A UN PROCEDIMIENTO PARA LA COMPROBACION DE ESTADOS DE SHOCK Y PARA CONTROL TERAPEUTICO DE PACIENTES CON ESTADO DE SHOCK DONDE SE DETERMINA LA CONCENTRACION DE CICLOFILINAS EN LA SANGRE DEL PACIENTE CON LA AYUDA DE (A) METODOS ENZIMOLOGICOS, (B) METODOS DE COMPROBACION INMUNOLOGICOS CON LA AYUDA DE ANTICUERPOS ESPECIFICOS, (C) PROCEDIMIENTO PEPTIDICO QUIMICO, (D) METODOS RADIOQUIMICOS, Y SIRVEN PARA LA VALORACION DEL GRADO DE GRAVEDAD DEL SHOCK, ASI COMO LA UTILIZACION DE MEDICAMENTOS, SUSTANCIAS ACTIVAS BIOLOGICAS Y METODOS FISICOQUIMICOS, QUE REDUCEN LA CONCENTRACION DE CICLOFILINA ACTIVA EN LA SANGRE DE PACIENTES CON SHOCK, PARA TERAPIA DEL SHOCK, EN PARTICULAR SHOCK SEPTICOS, SHOCK POSTOPERATIVOS Y SHOCK TOXICOS.
ES95935420T 1994-10-12 1995-09-30 Procedimiento para la evaluacion diagnostica y el control de la evolucion de estados de choque en seres humanos, asi como medicamentos para su terapia. Expired - Lifetime ES2150585T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4436352A DE4436352A1 (de) 1994-10-12 1994-10-12 Verfahren zur diagnostischen Beurteilung und Verlaufskontrolle sowie Arzneimittel zur Therapie von Schockzuständen beim Menschen

Publications (1)

Publication Number Publication Date
ES2150585T3 true ES2150585T3 (es) 2000-12-01

Family

ID=6530515

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95935420T Expired - Lifetime ES2150585T3 (es) 1994-10-12 1995-09-30 Procedimiento para la evaluacion diagnostica y el control de la evolucion de estados de choque en seres humanos, asi como medicamentos para su terapia.

Country Status (12)

Country Link
US (2) US6066465A (es)
EP (1) EP0786083B1 (es)
JP (1) JPH10507184A (es)
AT (1) ATE195375T1 (es)
CA (1) CA2202465A1 (es)
DE (2) DE4436352A1 (es)
DK (1) DK0786083T3 (es)
ES (1) ES2150585T3 (es)
GR (1) GR3034741T3 (es)
PT (1) PT786083E (es)
RU (1) RU2164026C2 (es)
WO (1) WO1996012184A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2147127C1 (ru) * 1998-07-14 2000-03-27 Иркутский государственный медицинский университет Минздрава РФ Способ дифференциальной диагностики анафилактического и анафилактоидного шока
GB0716804D0 (en) * 2007-08-29 2007-10-10 Univ Court Of The University O Identifying organ damage
EP2387391B1 (de) * 2009-07-24 2017-01-11 MIKA Pharma Gesellschaft für die Entwicklung und Vermarktung pharmazeutischer Produkte mbH Verfahren zur entwicklung einer als schaum auf die haut zu applizierenden flüssigen zusammensetzung sowie eine topisch applizierbare zusammensetzung

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3416620A (en) * 1967-03-01 1968-12-17 Stanley A. Mcclusky Bag filling and weighing machine
US3733840A (en) * 1971-05-17 1973-05-22 Canteen Corp Method and apparatus for inhibiting bacterial growth in automatic icemakers
US3774625A (en) * 1972-02-09 1973-11-27 Ultra Dynamics Corp Carwash water reclaim system
JPS58501544A (ja) * 1981-09-08 1983-09-16 ザ　ロツクフエラ−　ユニヴア−シテイ エンドトキシン誘発メディエ−タ−（ショック検定）によるリポプロティンリパ−ゼの抑圧
US4722999A (en) * 1985-05-03 1988-02-02 Yale University Cyclophilin
US5047512A (en) * 1985-05-03 1991-09-10 Handschumacher Robert E Immobilized cyclophilin and methods of using such
AT389947B (de) * 1987-04-03 1990-02-26 Woloszczuk Wolfgang Dr Verfahren zur bestimmung des aktuellen pegels von cyclosporin-a bzw. des diesem verwandter immunsuppressiva sowie jenes deren biologisch aktiver metaboliten im blut
GB8725529D0 (en) * 1987-10-30 1987-12-02 Delta Biotechnology Ltd Polypeptides
EP0326067A3 (en) * 1988-01-26 1991-04-17 The Du Pont Merck Pharmaceutical Company Use of cyclophilin as an anti-inflammatory and immunomodulatory agent
US5109651A (en) * 1990-10-05 1992-05-05 Packaged Ice, Inc. Ice bagger
US5604105B1 (en) * 1990-10-12 1999-08-24 Spectral Diagnostics Inc Method and device for diagnosingand distinguishing chest pain in early onset thereof
AU1531492A (en) * 1991-02-14 1992-09-15 Rockefeller University, The Method for controlling abnormal concentration tnf alpha in human tissues
CA2114942A1 (en) * 1991-08-05 1993-02-18 Jeffrey S. Friedman Novel cyclophilins, associating proteins and uses
CA2190275A1 (en) * 1994-05-18 1995-11-23 Thomas Hermann Screening for cytokine modulators

Also Published As

Publication number Publication date
EP0786083A1 (de) 1997-07-30
RU2164026C2 (ru) 2001-03-10
US20020039756A1 (en) 2002-04-04
DE59508630D1 (de) 2000-09-14
JPH10507184A (ja) 1998-07-14
ATE195375T1 (de) 2000-08-15
GR3034741T3 (en) 2001-02-28
EP0786083B1 (de) 2000-08-09
DK0786083T3 (da) 2000-12-18
CA2202465A1 (en) 1996-04-25
US6066465A (en) 2000-05-23
DE4436352A1 (de) 1996-04-18
PT786083E (pt) 2000-12-29
WO1996012184A1 (de) 1996-04-25

Similar Documents

Publication Publication Date Title
UA32429C2 (uk) Засіб для лікування нетримання сечі
ES2168302T3 (es) Tratamiento de trastornos y estados neuromusculares con toxina botulinica de serotipo e.
DE69632601D1 (de) Auf Kodes für Herzschläge basierendes Gerät für Diagnose und Behandlung von Herzarryhythmie
AU1916995A (en) 4-amino derivatives of mycophenolic acid with immunosuppressant activity
CA2006473A1 (en) Improved anti-infective therapy
FR2703254B1 (fr) Dispositif de traitement thérapeutique d'un tissu pathologique, comportant un cathéter .
FR2740978B1 (fr) Dispositif medical actif du type defibrillateur/cardioverteur implantable
SI0745075T1 (en) 6-substituted mycophenolic and derivatives with immunosuppressive activity
GR3031250T3 (en) Methods of diagnosing and treating preeclampsia
DE68911975D1 (de) Ophthalmoskopisches Diagnoseverfahren und Gerät.
HU9301253D0 (en) Medical preparative applicable for treatment of enlarged time of coagulation
WO1996000576A3 (de) Neue klinische anwendungen von polyen-makroliden
DE3875866D1 (de) Sulfonamidolphenyl-derivate und diese enthaltende therapeutische und vorbeugend wirkende mittel gegen arrhythmie.
KR950700726A (ko) 치료 또는 진단용 조성물, 그 제조방법 및 용도(composition for therapeutic or diagnostic use, process for its preparation and its use)
EP0758021A3 (en) Method for determining the therapeutic activity of metalloproteinase inhibitor compounds, new inhibitor compounds, and the therapeutic use thereof
DE69824119D1 (de) Implantierbare aktive medizinische Einrichtung, insbesondere Herzstimulator, gesteuert von wenigstens einem physiologischen Parameter
IT1290781B1 (it) Agente attivo terapeutico per il trattamento di malattie degenerative neuronali.
ES2150585T3 (es) Procedimiento para la evaluacion diagnostica y el control de la evolucion de estados de choque en seres humanos, asi como medicamentos para su terapia.
DE69935743D1 (de) Aktive implantierbare medizinische Vorrichtung, insbesondere mehrstelliger Herzstimulator, Defibrillator und/oder Kardiovertierer
DE68911076D1 (de) Halogenierter und hydrierter Acrylonitril-Butadien-Kautschuk.
GR3032224T3 (en) Therapeutic agent for threatened abortion.
DE68911974D1 (de) Ophthalmologisches Diagnose-Verfahren und Gerät.
DE68918233D1 (de) Katheter für diagnose und therapie.
DE69624782D1 (de) Elektrodenzuleitung für implantierbare medizinische Vorrichtung, insbesondere für Herzschrittmacher
BR9403337A (pt) Eletrodo extrudado configurado como corpo composto

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 786083

Country of ref document: ES